Retatrutide 20mg
Retatrutide
Commonly Researched For
A next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors—currently in advanced clinical trials for obesity and metabolic disorders. It’s being studied for its potent effects on appetite regulation, insulin sensitivity, and lipid metabolism.
Disclaimer
All research peptides sold by Boost Lab Australia undergo independent third-party testing to verify composition and purity prior to sale and are provided for research and laboratory use only.
⚠️ IMPORTANT AUSTRALIAN COMPLIANCE DISCLAIMER
This material is supplied for laboratory research purposes only.
RETA is not approved by the Therapeutic Goods Administration (TGA) for human or veterinary use. Nothing in this document is intended to provide, nor should it be interpreted as, medical advice, dosing guidance, or instructions for administration to any person or animal.
The supplier and author accept no liability for misuse, off-label application, or reliance on this material outside its intended research context.